Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees

On July 1, 2026, Autolus Therapeutics plc (NASDAQ:AUTL) announced that the Compensation Committee of its Board of Directors granted banal enactment awards to acquisition an aggregate of 25,420 American Depositary Shares and 87,530 restricted banal units to 13 employees nether the company's 2025 Inducement Plan. The awards were granted arsenic inducement worldly to the individuals becoming employees of Autolus successful accordance with Nasdaq Listing Rule 5635(c)(4).

The banal enactment awards and RSUs person a assistance day of June 24, 2026. The banal options person an workout terms of $1.66 per share, adjacent to the closing terms of Autolus' communal banal connected June 23, 2026. Each banal enactment grant has a ten-year word and vests implicit 4 years, portion each RSU vests successful 4 adjacent yearly installments, taxable to continued work done the applicable vesting dates.

Over a period ago, H.C. Wainwright raised the firm's terms people connected Autolus Therapeutics to $10 from $9 and kept a Buy standing connected the shares aft the Q1 report. H.C. Wainwright said the company's Aucatyzl U.S. request is growing, portion the UK motorboat is disconnected to a affirmative start.

Autolus Therapeutics plc (NASDAQ:AUTL) develops T compartment therapies for the attraction of crab and autoimmune diseases successful the United Kingdom and internationally.

While we admit the imaginable of AUTL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.